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Summary: Proteus syndrome is a rare genetic disorder first described in 1979 and named after Proteus, a Greek demigod who 
was capable of changing his form to avoid capture. The incidence is < 1:1 000 000, but can be expected to be slightly higher in 
the surgical population, as these patients often present for repeat procedures. The disorder is characterised by sporadic and 
progressive overgrowth of tissue of any origin. Normal anatomy usually becomes distorted and serious functional and cosmetic 
sequelae may ensue. Regular anaesthetic interventions are required for diagnostic and therapeutic procedures, often to correct 
deformities related to overgrowth, tumour excision and otolaryngological procedures. Literature relating to the anaesthetic 
management of patients with Proteus syndrome is limited to case reports describing instances of general anaesthesia. 
Complications of general anaesthesia secondary to respiratory tract abnormalities appear prevalent. Regional anaesthesia is 
often used when respiratory compromise is anticipated due to any cause. Despite this, current guidelines suggest that regional 
anaesthesia be avoided in patients with Proteus syndrome, due to the gross anatomical variance and the high incidence of 
vascular abnormalities in these patients. The use of ultrasound-guided neural block enables practitioners to distinguish nerves 
from vascular structures and other tissues. It helps avoid neural injury during needle placement and improves success rate. 
This case report is the first to demonstrate the successful use of an ultrasound-guided regional anaesthetic technique in a boy 
requiring surgery to his right forearm.
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Case presentation
A four-year-old boy (15  kg) with Proteus syndrome required 
debulking surgery of soft tissue overgrowth of his right forearm. 
This overgrowth appeared adipose in nature and was so 
excessive that he was unable to use the fingers on his right hand 
to grasp. To correct this, a staged debulking procedure was 
planned at an academic orthopaedic centre.
He had been diagnosed with Proteus syndrome as an infant, 
following disproportionate overgrowth of especially his right arm. 
It was noticed in the first three months of his life and appeared to 
accelerate over the next few years. The soft tissue overgrowth of the 
right arm involved the entire arm and included part of the thoracic 
wall. He also had overgrowth of the left forearm. He had marked 
lipodystrophy over the thoracic cage and a cerebriform nevus over 
the palmar surface of the left hand. Despite being microcephalic, 
he had normal neurodevelopmental milestones. There was no 
family history of genetic disease. He had had one previous 
uneventful general anaesthetic for debulking of the same arm.
Plain film X-ray of the arms showed distortion of phalanges as 
well as the carpal and metacarpal bones bilaterally, slight bowing 
of the right radius and ulna with normal humeri bilaterally. An 
MRI scan revealed a structurally normal brachial plexus on the 
right, surrounded by excess tissue which appeared to be adipose 
in nature. Vascular structures were normal, as was his chest X-ray.
Oral paracetamol 225 mg was administered one hour preoperatively. 
Inhalational induction was performed with sevoflurane/oxygen/
nitrous oxide and IV access secured. After ensuring adequate bag-
mask ventilation, fentanyl 30 μg, propofol 30 mg and cis-atracurium 
2.25  mg were administered to facilitate intubation. No airway 
abnormalities were observed during laryngoscopy and intubation 
was easily performed using a size 5.0 cuffed endotracheal tube. 
Maintenance was with isoflurane, oxygen 40% and air. Standard 
American Association of Anesthesiologists monitoring was used.
A supra-clavicular brachial plexus block was performed using a 
50  mm Arrow Stimu-quick needle with ultrasound guidance 
(Ezono, 13-6 mHz linear probe). Adequate imaging of landmark 
structures was obtained. Bupivacaine 0.25% was used and 8 ml 
injected with adequate local anaesthetic spread visualised 
around the brachial plexus. A further 2 ml was injected over the 
medial upper arm for tourniquet pain. At the end of the 
procedure, diclofenac 12.5 mg was given rectally.
The procedure lasted three hours with no additional analgesia 
required. A tourniquet was used for part of the procedure. The 
total tourniquet time was 46 minutes. On emergence the child 
was calm with no pain. Routine postoperative analgesia was 
prescribed (oral paracetamol 225 mg 6-hourly, ibuprofen 75 mg 
8-hourly). No postoperative opioids were required.
Ethical approval to publish this case was obtained from the 
Ethics Committee of the Faculty of Health Sciences, University of 
the Free State in Bloemfontein, South Africa. Informed consent 
was obtained from the child’s mother.
Discussion
Proteus syndrome typically presents with sporadic and 
progressive overgrowth of tissue of any origin, with lesions 
occurring in a mosaic distribution.1−3 It is agreed that the syndrome 
is likely due to a post-zygotic somatic mutation which survives by 
mosaicism, and is fatal to the conceptus when constitutive.1,4 
Recent work has shown an association with a mutation in the 
AKT1 oncogene which encodes for AKT kinase, an enzyme 
responsible for mediating processes such as cellular proliferation 
and apoptosis.1
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Owing to the phenotypic heterogeneity as well as the rarity of 
this syndrome, controversy surrounding the clinical diagnosis 
remains.2,3 Clinical overlap with other overgrowth entities exists 
and many suggest that Proteus syndrome should be seen as part 
of a spectrum of similar disorders.1−3 Recent guidelines 
recommend the use of stringent diagnostic criteria. Advocates 
cite different aetiologies and clinical courses as reasons for 
precise diagnosis.2,3,5 Indeed, when these criteria were matched 
to reported cases of Proteus syndrome, it was found that fewer 
than 50% of these patients actually had Proteus syndrome.5
This syndrome poses unique challenges to the anaesthetist and 
very few case reports are available in the literature to guide our 
practice.6−11 Most commonly bone, connective tissue, adipose 
tissue and vasculature are affected, but any tissue can be 
involved.6 The systemic manifestations relevant to anaesthesia 
are summarised in Table 1.
Airway problems have been described in many case reports6,8,9,12 
and a thorough airway assessment is necessary. Airway 
abnormalities, such as abnormal facial architecture, may be 
obvious. This would complicate bag-mask ventilation. However, 
unanticipated airway complications, which can be life-
threatening, have been described.7,9 Equipment for a difficult 
airway should be available immediately whenever a patient with 
Proteus syndrome is to receive anaesthesia.9,10 For patients with 
preoperative symptoms or signs of upper airway obstruction, 
sedative premedication and perioperative opioids should be 
avoided and the patient should be nursed in a high care unit 
postoperatively.
Pulmonary manifestations are of particular interest and 
perioperative respiratory failure has been described.13 Careful 
pulmonary interrogation and investigation are vital. Pulmonary 
manifestations can be classified as primary or secondary.2,3,14
Primary (parenchymal) manifestations include cystic lung 
changes and expanding multi-lobular bullae.14 Mucous retention 
and atelectasis can be expected. This is known to complicate as 
progressive emphysematous pulmonary disease.13,14 Pulmonary 
venous varicosities can occur, and may lead to airway obstruction 
or rupture with life-threatening haemoptysis.14 Secondary 
manifestations can result from thoracic cage abnormalities. The 
incidence of kyphoscoliosis in patients with Proteus syndrome is 
as high as 50%,15 and can result in severely restrictive lung 
function, which could mask an obstructive picture caused by 
emphysematous disease.
Cases with radiological evidence of primary pulmonary disease in 
asymptomatic individuals have been reported and poor mobility 
could also mask respiratory symptoms.13,14 Severe thoracic cage 
abnormalities could hide underlying primary disease on X-ray.13 
An argument could be made that all patients should have a 
preoperative chest X-ray, and if any doubt arises a high-resolution 
CT of the chest should be performed. Nitrous oxide should be 
avoided in confirmed cases of cystic lung disease.13
If pulmonary manifestations are suspected, vigorous postoperative 
bronchial toilet and early extubation and ambulation are required 
to avoid mucous retention, atelectasis and respiratory 
compromise.13
Primary cardiac manifestations are not regarded as a hallmark of 
this syndrome.2,3 There has been a case report of cardiomyopathy 
and a myocardial mass in a patient with Proteus syndrome, but 
concerns as to whether this patient met the diagnostic criteria 
have been raised.5 A small patent ductus arteriosus has been 
reported.11 Cardiovascular illness secondary to pulmonary 
disease occurs and pulmonary hypertension should be excluded.
The vascular system itself is often affected and deep venous 
thromboses and pulmonary emboli are common.2,3,5,16,17 This is likely 
due to vascular malformations, distorted anatomy and decreased 
mobility. Hypercoagulability per se has not been described.16 
Consensus has not been reached regarding perioperative 
anticoagulant prophylaxis and should be considered on a patient-
to-patient basis.2,3,17 Careful postoperative monitoring for 
thromboses and early ambulation should be encouraged.17
Nervous system manifestations are quite common but usually 
asymptomatic and often related to skeletal abnormalities. 
Seizure disorders and mental retardation are often related to 
underlying structural abnormalities. Intracranial neoplasms have 
been described.5 Dural sinus thrombosis has been reported18 
and obstruction to dural venous drainage must be avoided and 
patients kept well hydrated. Spinal abnormalities (including 
skeletal abnormalities and vascular malformations) are highly 
prevalent2,3,5 and neuraxial techniques can be technically difficult 
and potentially hazardous. Ultrasound-guided placement of an 
epidural catheter without complication has been described.9
Abdominal problems are varied. Gut wall hamartomas can cause 
gastric outlet obstruction.3 Splenomegaly can occur.9 Renal 
abnormalities, in both structure and function, have been 
reported. This may be related to local anatomical obstruction 
Table 1: Systematic considerations in Proteus syndrome of importance for the anaesthesiologist
System Consideration Suggestion
Airway Difficult bag-mask ventilation; obstruction; failed intubation
Formal preoperative evaluation; difficult-airway aids 
in theatre
Respiratory Severe obstructive and/or restrictive disease; pulmo-nary haemorrhage
Functional assessment; arterial blood gas analysis; 
high-resolution CT; avoid intubation and ventilation
Cardiovascular Venous thromboembolism; fatal pulmonary embolism
Early ambulation; careful postoperative monitoring; 
anticoagulation on individual basis
Central nervous Venous stroke; neoplasms Support venous drainage; adequate hydration
Gastrointestinal Gastric outlet obstruction Rapid-sequence intubation
Genitourinary Functional impairment; diabetes insipidus Formal preoperative evaluation
Miscellaneous Any organ system can be involved Evaluate on a case-to-case basis; not at risk for malig-nant hyperthermia
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causing hydronephrosis, urinary reflux with recurrent infections 
or possibly intra-parenchymal processes. The latter may also be 
responsible for nephrogenic diabetes insipidus.5,19
Owing to the variable presentation of patients with Proteus 
syndrome, patients requiring anaesthesia need to be evaluated 
on an individual basis. Despite anticipated problems with 
general anaesthesia, it has generally been preferred over regional 
techniques. Although muscular overgrowth occurs, Proteus 
syndrome is not regarded as a muscular disease or a malignant 
hyperthermia risk factor.6,10 The high incidence of vascular, 
skeletal and soft tissue abnormalities has made the placing of 
neural blocks difficult. However, the growing experience with 
ultrasound-guided regional anaesthesia could change this 
obstacle as structures can now be visualised and neural blocks 
safely performed.
This case study has demonstrated how, despite distorted 
anatomy, a young patient with Proteus syndrome requiring 
forearm surgery successfully received a supraclavicular block, 
using an ultrasound-guided technique for needle placement. We 
recommend that practitioners experienced in ultrasound-
guided neural blockade perform regional anaesthesia in selected 
patients with Proteus syndrome.
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